Akero Therapeutics Ownership | Who Owns Akero Therapeutics?
Akero Therapeutics Ownership Summary
Akero Therapeutics is owned by 105.12% institutional investors, 5.34% insiders. Janus henderson group is the largest institutional shareholder, holding 11.59% of AKRO shares. Vanguard Health Care Inv is the top mutual fund, with 6.34% of its assets in Akero Therapeutics shares.
AKRO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Akero Therapeutics | 105.12% | 5.34% | -10.46% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 6.88M | 11.59% | $161.28M |
| Blackrock | 5.59M | 9.42% | $131.06M |
| Rtw investments, lp | 5.43M | 9.16% | $127.43M |
| General atlantic | 5.23M | 8.83% | $122.79M |
| Wellington management group llp | 5.11M | 8.62% | $119.99M |
| Price t rowe associates inc /md/ | 4.15M | 6.99% | $97.28M |
| Vanguard group | 3.71M | 6.25% | $86.92M |
| Alkeon capital management | 3.33M | 5.61% | $78.06M |
| State street | 2.69M | 4.53% | $63.09M |
| Alliancebernstein | 1.91M | 3.22% | $44.76M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| University of wisconsin foundation | 423.85K | 11.19% | $9.94M |
| Propel bio management | 327.75K | 4.99% | $7.69M |
| General atlantic | 5.23M | 3.86% | $122.79M |
| Silverarc capital management | 625.09K | 3.46% | $14.66M |
| Yiheng capital management | 1.43M | 2.71% | $33.65M |
| Redmile group | 1.61M | 2.29% | $37.88M |
| Boxer capital | 1.68M | 2.07% | $39.34M |
| Rtw investments, lp | 5.43M | 1.97% | $127.43M |
| Logos global management lp | 800.00K | 1.51% | $18.77M |
| Bioimpact capital | 385.99K | 1.41% | $9.06M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 6.88M | 0.09% | 754.28K |
| Blackrock | 5.59M | 0.00% | 694.02K |
| T. rowe price investment management | 1.77M | 0.03% | 665.19K |
| Morgan stanley | 946.53K | 0.00% | 542.66K |
| Long focus capital management | 719.60K | 0.65% | 391.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Baker bros. advisors lp | 1.10M | 0.33% | -1.62M |
| Fred alger management | 123.79K | 0.01% | -1.21M |
| State street | 2.69M | 0.00% | -1.11M |
| Braidwell lp | - | - | -1.08M |
| Artisan partners limited partnership | - | - | -303.92K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Corebridge financial | 36.47K | 0.00% | 36.47K | $855.66K |
| Mirae asset global etfs | 35.47K | 0.00% | 35.47K | $831.83K |
| Trexquant investment lp | 24.65K | 0.01% | 24.65K | $578.31K |
| Two sigma advisers, lp | 18.10K | 0.00% | 18.10K | $424.63K |
| American century companies | 14.81K | 0.00% | 14.81K | $347.47K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Riggs asset managment | -14.00 |
| Ica group wealth management | -110.00 |
| Pacer advisors | -688.00 |
| Banque cantonale vaudoise | -1.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 180 | 14.65% | 72,997,386 | 1.71% | 105 | 0.72% | 85 | 8.97% | 57 | 7.55% |
| Jun 30, 2024 | 157 | -15.14% | 71,768,872 | -1.77% | 121 | 0.80% | 78 | -29.09% | 53 | 12.77% |
| Mar 31, 2024 | 185 | 8.82% | 73,065,461 | 23.85% | 123 | 1.10% | 110 | 25.00% | 47 | -2.08% |
| Dec 31, 2023 | 170 | -21.30% | 58,992,846 | 3.30% | 105 | 1.00% | 88 | -29.60% | 48 | 29.73% |
| Sep 30, 2023 | 216 | 22.03% | 57,109,194 | 0.85% | 102 | 0.86% | 125 | 26.26% | 37 | -5.13% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 4.40M | 6.34% | 2.86M |
| Janus Henderson Global Life Sciences | 2.01M | 2.89% | -118.09K |
| Vanguard Total Stock Mkt Idx Inv | 1.94M | 2.78% | 20.95K |
| iShares Russell 2000 ETF | 1.82M | 2.61% | -7.00K |
| T. Rowe Price New Horizons | 1.78M | 2.55% | - |
| US Small-Cap Growth II Equity Comp | 1.78M | 2.55% | -33.35K |
| Janus Henderson Global Life Sciences D | 1.67M | 2.39% | -122.47K |
| Janus Global Life Science AUSD | 1.50M | 2.14% | -51.08K |
| Janus Henderson Glb Life Scn I2 USD | 1.32M | 1.89% | -49.87K |
| Vanguard Institutional Extnd Mkt Idx Tr | 954.54K | 1.37% | -6.36K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 27, 2025 | Rolph Timothy | Chief Scientific Officer | Sell | $281.38K |
| Jan 27, 2025 | Rolph Timothy | Chief Scientific Officer | Sell | $705.23K |
| Jan 27, 2025 | Rolph Timothy | Chief Scientific Officer | Sell | $756.35K |
| Jan 27, 2025 | Lamy Patrick | Senior VP, Commercial Strategy | Sell | $285.15K |
| Jan 27, 2025 | Cheng Andrew | President and CEO | Sell | $1.32M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 31 |
| 2024 Q3 | - | 26 |
| 2024 Q2 | - | 10 |
| 2024 Q1 | - | 12 |
| 2023 Q4 | 4 | 16 |
AKRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools